STOCK TITAN

Lifecore Biomedical, Inc. (LFCR) EPS by Year

LFCR

Lifecore Biomedical, Inc. lost $1.27 per diluted share in fiscal year 2025. This represents a decrease of 484.8% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Lifecore Biomedical, Inc. has filed alongside them.

FY2025 annual
EPS (Diluted) -$1.27
YoY -484.8%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

LFCR EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
EPS (Diluted)-$1.27-484.8%$0.33+109.9%-$3.32+16.4%-$3.97-260.9%-$1.10+16.0%-$1.31-13200.0%$0.01-98.9%$0.89+134.2%$0.38+188.4%-$0.43-186.0%$0.50-29.6%$0.71-16.5%$0.85+73.5%$0.49+226.7%$0.15

LFCR EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-Q
EPS (Diluted)-$0.19-$0.43N/A-$0.29-16.0%-$0.06-$0.42-200.0%-$0.25-164.1%-$0.53-51.4%-$0.20+84.8%$0.42+135.0%$0.39+190.7%-$0.35+5.4%

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Lifecore Biomedical, Inc. financials

Frequently Asked Questions

What was Lifecore Biomedical, Inc.'s diluted earnings per share in fiscal year 2025?

Lifecore Biomedical, Inc. lost $1.27 per diluted share in fiscal year 2025.

How fast is Lifecore Biomedical, Inc.'s diluted earnings per share growing?

Lifecore Biomedical, Inc. (LFCR) diluted earnings per share fell by 484.8% year over year, from $0.33 to -$1.27 in fiscal year 2025.

How has Lifecore Biomedical, Inc.'s diluted earnings per share changed over the years?

Across the 15 fiscal years this page covers, Lifecore Biomedical, Inc. (LFCR) diluted earnings per share went from $0.15 in fiscal year 2011 to -$1.27 in fiscal year 2025.

Lifecore Biomedical, Inc. (LFCR) reported -$0.19 in diluted earnings per share in Q1 2027.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Lifecore Biomedical, Inc. (LFCR) reported on that line in every period on record.